Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies
- 14 January 2003
- journal article
- clinical trial
- Published by Wiley in Transfusion
- Vol. 43 (1), 50-57
- https://doi.org/10.1046/j.1537-2995.2003.00273.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer TherapyJournal of Clinical Oncology, 2000
- Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cellsThe Lancet, 1999
- A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritisBone Marrow Transplantation, 1998
- Stem cell mobilisation in lymphoproliferative diseasesBone Marrow Transplantation, 1998
- Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastimBritish Journal of Haematology, 1998
- Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cellsTransfusion, 1998
- Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet RecoveryJournal of Hematotherapy, 1996
- Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patientsThe Lancet, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patientsBlood, 1995